Financial Reports Latest Updates Industry Maps Economic Calendar

AtriCure, Inc. (ATRC) Annual Reports

Q: Where can I read AtriCure, Inc. (ATRC) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

AtriCure, Inc. is listed on Nasdaq, classified by the SEC under Surgical & Medical Instruments & Apparatus (SIC 3841). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1323885 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$153.6M	$136.1M	+12.8%
Operating income	$9.7M	$-6.2M	+256.1%
Net income	$9.0M	$-6.2M	+244.7%
EPS (diluted)	$0.18	$-0.13	+238.5%

Company guidance
	Period	Range
Adjusted EPS	FY2026	$0.05 – $0.13

Figures are the company’s own outlook as stated in its earnings release, not analyst estimates.

Source: SEC EDGAR (XBRL company facts); guidance from Form 8-K Exhibit 99.1

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 154 mn Net income 8.96 mn

Show table：Income statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	54.5	14.2	14.5	16.4	15.6	16.8	15.2	16.8	17.5	18.3	16.1	18.4	19.4	20.4	20.1	21.9	24.9	26.5	26.7	29.4	29.9	32.6	31.4	35.9	35.9	39.7	38.3	41.2	41.3	45.2	42.1	46.1	47.0	51.8	49.9	52.9	54.0	58.9	56.6	61.3	53.2	40.8	54.8	57.7	59.3	71.4	70.5	73.2	74.6	84.5	83.3	88.0	93.5	101	98.3	107	109	116	116	124	124	136	134	141	141	154
Gross profit	41.8	11.2	11.2	12.3	11.9	12.3	11.1	11.7	12.8	12.7	11.6	13.0	14.1	15.1	14.7	15.7	17.7	18.8	18.9	20.4	21.7	23.1	22.5	25.6	25.9	28.8	27.5	28.9	30.0	32.5	30.9	32.7	34.5	38.1	36.0	38.6	39.9	43.9	41.8	44.8	38.9	27.6	40.3	42.4	44.5	54.1	52.2	55.0	55.6	63.5	61.7	65.1	69.6	77.1	73.9	79.8	81.3	86.8	86.8	92.6	92.6	101	101	105	109	119
Operating income	-15.5	-0.43	-0.83	-0.24	-1.07	-0.77	-1.19	-1.69	-1.50	-1.32	-2.53	-1.85	-1.80	-1.64	-2.61	-4.84	-7.92	-2.85	-0.8	-4.78	-5.14	-4.82	-6.13	-10.6	-9.42	-7.74	-6.29	-7.69	-9.64	-6.35	-6.85	-2.13	-9.43	0.96	-6.05	-2.61	-5.32	-3.84	-8.64	-15.3	-15.4	-7.28	-3.99	-17.5	-15.9	-15.1	98.7	-12.5	-14.2	-13.7	-10.7	-4.14	-5.78	-4.14	-8.09	-8.67	-10.9	-7.17	-7.40	-14.5	-5.95	-6.19	0.21	2.49	0.53	9.66
Net income	-16.5	-0.76	-1.03	0.01	-1.27	-0.95	-1.16	-2.08	-1.62	-1.33	-2.57	-2.02	-1.94	-1.79	-2.75	-4.98	-7.71	-2.69	-0.47	-5.34	-5.27	-4.89	-6.14	-10.9	-9.72	-8.21	-6.78	-8.62	-10.2	-6.88	-7.25	-2.58	-10.1	-0.34	-7.23	-3.43	-5.63	-4.10	-9.36	-16.1	-16.4	-8.24	-4.95	-18.6	-16.9	-16.3	97.1	-13.7	-15.2	-14.8	-12.3	-4.17	-6.48	-5.12	-9.05	-9.79	-13.3	-8.01	-7.85	-15.6	-6.75	-6.19	-0.27	1.76	0.11	8.96

Balance sheet

Quarterly · In mn (USD)

Total assets 677 mn Total liabilities 160 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	30.6	—	33.0	31.7	31.2	33.1	31.4	30.1	28.5	54.4	53.5	48.6	52.5	107	92.8	90.7	93.5	93.4	90.7	84.1	74.8	65.4	86.5	84.4	85.7	79.1	81.1	82.2	82.3	84.8	86.8	88.4	175	155	147	138	143	127	292	296	307	298	236	196	196	200	206	212	215	238	238	253	266	245	253	269	268	251	271	301	323	314	346
Total assets	—	—	—	33.7	—	36.1	34.1	33.9	36.6	36.0	33.7	32.4	58.1	57.5	57.6	112	159	156	157	158	153	159	166	273	262	282	279	276	266	269	268	268	270	271	272	357	338	343	561	558	528	704	708	715	700	701	613	615	585	587	582	585	583	594	600	614	592	597	615	609	592	609	635	654	644	677
Current liabilities	—	—	—	13.0	—	10.6	9.97	10.8	11.8	11.7	11.6	12.2	12.7	13.4	16.3	26.7	16.0	16.9	21.9	25.6	24.6	30.1	39.1	31.6	26.2	25.2	26.5	28.8	28.4	31.7	36.1	31.9	26.9	27.4	33.7	40.2	35.5	39.4	44.3	49.9	39.1	38.0	44.8	49.1	58.5	67.4	54.0	56.5	47.4	56.3	57.6	58.4	62.5	71.4	82.5	74.6	61.3	61.2	74.4	73.4	61.2	68.8	77.8	81.5	73.2	81.9
Total liabilities	—	—	—	17.0	—	19.2	18.0	18.2	21.9	21.1	20.2	19.9	19.5	19.3	21.4	39.3	24.3	21.7	22.1	25.9	24.9	30.6	40.2	86.4	80.7	105	106	108	106	107	110	107	117	111	108	107	99.1	102	303	311	300	287	290	302	309	316	125	132	122	131	132	129	128	132	137	148	135	135	150	148	137	144	159	162	152	160
Equity	17.1	—	—	16.7	—	16.9	16.1	15.6	14.7	14.9	13.6	12.5	38.6	38.1	36.2	72.6	134	134	135	133	129	129	125	187	181	177	173	168	161	162	159	161	153	160	164	249	239	242	258	247	227	417	418	412	391	385	488	484	463	457	450	457	455	462	463	466	456	462	465	461	455	464	477	492	492	516

Cash flow

Quarterly · In mn (USD)

Operating 22.2 mn Investing -3.77 mn Financing 3.26 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	0.42	-1.88	0.32	1.53	-0.87	0.37	-0.36	-1.13	-1.08	-0.2	-0.46	-0.19	-2.57	-0.26	0.67	-3.06	-14.4	-3.97	-1.21	-2.01	-8.97	2.58	2.63	-4.08	-10.9	-6.02	1.08	0.76	-9.55	-1.06	0.13	1.53	-9.43	-0.93	5.21	0.99	-13.4	3.75	-2.59	-3.53	-16.1	-11.6	3.81	3.95	-9.32	-4.53	-0.23	0.3	-24.6	4.23	-1.78	0.05	-4.08	3.01	1.52	4.03	-21.0	7.38	20.0	5.84	-11.0	21.6	26.7	20.0	-4.00	22.2
Investing	-2.17	0.65	-3.30	-0.69	0.07	-4.58	0.31	6.93	-0.7	-2.57	0.48	-0.01	-1.45	0.61	-5.38	-7.94	7.41	-23.5	-5.14	-9.44	2.56	-1.28	-9.04	-2.73	7.00	-20.9	-5.01	6.81	5.73	-0.43	-2.60	1.07	-4.24	-9.73	-0.6	-70.8	11.0	-0.93	-9.63	-2.60	17.3	-113	-58.7	-1.98	63.6	-16.1	-25.1	1.08	19.7	20.5	-3.24	7.00	28.8	-16.1	11.9	-2.79	9.64	30.9	4.39	-14.7	-1.68	-7.66	-2.60	-2.60	-3.85	-3.77
Financing	-0.91	-0.92	-0.41	-0.12	4.33	0.68	-0.59	0.42	3.44	0	-0.52	-0.25	27.1	-0.08	-0.51	0.28	60.7	0.77	-0.05	4.42	1.82	5.09	5.14	1.91	0.79	26.1	0.12	0.65	-1.22	3.31	0.88	-0.21	13.1	3.41	-0.43	84.1	-8.97	1.70	20.3	1.35	-7.83	191	-0.3	6.45	-10.7	2.82	-2.26	2.51	-10.5	1.86	-0.4	1.98	-5.52	2.99	0.13	2.36	-7.86	2.85	-0.33	1.74	-10.3	3.42	5.98	2.10	-13.3	3.26
Cash at period end	8.91	6.85	3.53	4.23	7.69	4.11	3.43	9.76	11.4	8.66	8.20	7.75	30.8	31.0	25.8	14.9	68.6	42.0	35.5	28.4	23.6	30.0	28.7	23.8	20.8	19.9	16.1	24.2	19.1	21.0	19.4	21.8	21.2	13.9	18.0	32.2	20.7	25.3	33.2	28.5	21.8	88.5	33.4	41.9	85.4	67.6	39.9	43.6	28.1	54.6	48.8	58.1	77.3	67.2	80.6	84.3	65.0	106	130	123	99.9	118	148	167	146	168

Profitability

Quarterly · %

Gross margin 77.2% Operating margin 6.3% Net margin 5.8%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	76.6%	79.1%	77.2%	75.1%	76.1%	73.2%	72.8%	70.0%	73.0%	69.6%	71.6%	70.8%	72.5%	74.0%	72.9%	71.6%	71.1%	70.8%	70.8%	69.4%	72.7%	71.0%	71.5%	71.2%	72.1%	72.6%	71.7%	70.2%	72.7%	72.0%	73.3%	71.0%	73.4%	73.5%	72.0%	73.0%	73.9%	74.5%	73.8%	73.0%	73.1%	67.7%	73.7%	73.5%	75.1%	75.8%	74.1%	75.1%	74.5%	75.1%	74.1%	74.0%	74.5%	76.4%	75.2%	74.9%	74.7%	74.7%	74.9%	74.5%	74.9%	74.5%	75.5%	75.0%	77.4%	77.2%
Operating margin	-28.4%	-3.0%	-5.7%	-1.4%	-6.9%	-4.6%	-7.8%	-10.1%	-8.6%	-7.2%	-15.7%	-10.1%	-9.3%	-8.0%	-13.0%	-22.1%	-31.9%	-10.8%	-3.0%	-16.3%	-17.2%	-14.8%	-19.5%	-29.6%	-26.2%	-19.5%	-16.4%	-18.7%	-23.4%	-14.1%	-16.2%	-4.6%	-20.1%	1.9%	-12.1%	-4.9%	-9.9%	-6.5%	-15.3%	-25.0%	-29.0%	-17.8%	-7.3%	-30.3%	-26.8%	-21.1%	140.0%	-17.1%	-19.0%	-16.2%	-12.9%	-4.7%	-6.2%	-4.1%	-8.2%	-8.1%	-10.0%	-6.2%	-6.4%	-11.7%	-4.8%	-4.5%	0.1%	1.8%	0.4%	6.3%
Net margin	-30.3%	-5.4%	-7.1%	0.1%	-8.1%	-5.6%	-7.6%	-12.4%	-9.3%	-7.3%	-15.9%	-11.0%	-10.0%	-8.8%	-13.6%	-22.8%	-31.0%	-10.2%	-1.8%	-18.2%	-17.6%	-15.0%	-19.5%	-30.4%	-27.1%	-20.7%	-17.7%	-21.0%	-24.7%	-15.2%	-17.2%	-5.6%	-21.6%	-0.7%	-14.5%	-6.5%	-10.4%	-7.0%	-16.5%	-26.3%	-30.8%	-20.2%	-9.0%	-32.2%	-28.5%	-22.8%	137.8%	-18.8%	-20.4%	-17.6%	-14.7%	-4.7%	-6.9%	-5.1%	-9.2%	-9.2%	-12.2%	-6.9%	-6.8%	-12.5%	-5.5%	-4.5%	-0.2%	1.3%	0.1%	5.8%

Returns & leverage

Quarterly · %

ROE 2.1% ROA 1.6% Debt ratio 23.7%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	-109.2%	—	-19.1%	-20.9%	-33.7%	-39.6%	-38.8%	-51.2%	-53.6%	-29.5%	-31.4%	-34.1%	-26.9%	-19.9%	-21.0%	-18.5%	-15.8%	-10.5%	-12.2%	-16.6%	-17.1%	-20.5%	-22.9%	-23.8%	-18.8%	-19.8%	-19.2%	-19.8%	-16.3%	-17.1%	-12.6%	-12.6%	-10.3%	-8.5%	-10.2%	-10.7%	-14.2%	-19.7%	-15.2%	-13.5%	-14.6%	-15.7%	-14.1%	10.0%	11.2%	12.2%	12.7%	-11.9%	-9.9%	-8.2%	-6.1%	-5.4%	-6.6%	-8.2%	-8.7%	-8.4%	-9.6%	-8.4%	-7.8%	-6.1%	-2.4%	-1.0%	2.1%
ROA	—	—	—	-54.2%	—	-9.0%	-9.9%	-16.1%	-15.9%	-17.1%	-22.4%	-22.7%	-16.6%	-17.8%	-18.6%	-15.9%	-15.9%	-17.0%	-14.8%	-12.0%	-8.8%	-10.1%	-13.4%	-12.6%	-15.3%	-15.9%	-16.0%	-12.1%	-12.8%	-11.8%	-12.0%	-9.9%	-10.0%	-7.5%	-7.5%	-6.8%	-5.5%	-6.7%	-5.4%	-7.7%	-10.6%	-9.6%	-7.2%	-7.6%	-7.9%	-8.1%	6.9%	7.5%	8.1%	8.3%	-9.4%	-7.7%	-6.5%	-4.8%	-4.2%	-5.1%	-6.3%	-6.7%	-6.4%	-7.3%	-6.5%	-6.0%	-4.6%	-1.8%	-0.7%	1.6%
Debt ratio	—	—	—	50.4%	—	53.2%	52.8%	53.9%	60.0%	58.5%	59.8%	61.5%	33.6%	33.6%	37.1%	35.1%	15.3%	13.9%	14.1%	16.3%	16.2%	19.2%	24.2%	31.6%	30.8%	37.1%	37.9%	39.1%	39.6%	39.9%	40.8%	39.8%	43.2%	41.0%	39.8%	30.1%	29.3%	29.6%	54.0%	55.7%	56.9%	40.8%	41.0%	42.3%	44.1%	45.1%	20.3%	21.4%	20.9%	22.3%	22.6%	22.0%	22.0%	22.2%	22.9%	24.1%	22.9%	22.6%	24.4%	24.4%	23.2%	23.7%	25.0%	24.8%	23.6%	23.7%

EPS

Quarterly · US$

EPS US$0.18

Show table：EPS

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.94	—	—	-0.11	-0.43	-0.38	-0.36	2.11	-0.30	-0.33	-0.32	-0.27	-0.09	-0.14	-0.11	-0.20	-0.21	-0.28	-0.17	-0.17	-0.33	-0.14	-0.13	-0.01	0.04	0.00	0.18

Revenue & profit

Year-to-date · In mn (USD)

Revenue 295 mn Net income 9.06 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 677 mn Total liabilities 160 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating 18.2 mn Investing -7.62 mn Financing -9.99 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 77.3% Operating margin 3.5% Net margin 3.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 2.1% ROA 1.6% Debt ratio 23.7%

EPS

Year-to-date · US$

EPS US$0.18

Revenue & profit

Annual · In mn (USD)

Revenue 535 mn Net income -11.4 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	64.4	70.3	81.9	107	130	155	175	202	231	207	274	330	399	465	535
Gross profit	47.0	50.0	59.6	75.8	92.9	111	126	147	170	149	206	246	300	348	401
Operating income	-4.73	-7.20	-10.9	-16.4	-26.7	-31.1	-25.0	-17.1	-33.1	-44.2	55.2	-42.7	-26.7	-40.0	-9.45
Net income	-5.46	-7.53	-11.5	-16.2	-27.2	-33.3	-26.9	-21.1	-35.2	-48.1	50.2	-46.5	-30.4	-44.7	-11.4

Balance sheet

Annual · In mn (USD)

Total assets 654 mn Total liabilities 162 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	31.2	28.5	52.5	93.5	74.8	85.7	82.3	175	143	307	196	215	266	268	323
Total assets	33.9	32.4	112	158	273	276	268	357	558	715	615	585	614	609	654
Current liabilities	10.8	12.2	26.7	25.6	31.6	28.8	31.9	40.2	49.9	49.1	56.5	58.4	74.6	73.4	81.5
Total liabilities	18.2	19.9	39.3	25.9	86.4	108	107	107	311	302	132	129	148	148	162
Equity	15.6	12.5	72.6	133	187	168	161	249	247	412	484	457	466	461	492

Cash flow

Annual · In mn (USD)

Operating 57.3 mn Investing -14.6 mn Financing 1.18 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-1.99	-1.94	-5.22	-21.6	-7.84	-15.1	-8.94	-4.17	-15.8	-19.9	-13.8	-22.1	4.48	12.2	57.3
Investing	2.72	-2.80	-14.2	-30.6	-10.5	-12.1	3.76	-85.4	-2.15	-156	23.5	44.0	21.8	30.2	-14.6
Financing	4.85	2.66	26.8	65.9	14.0	27.7	2.76	100	14.4	189	-7.64	-7.06	-0.03	-3.60	1.18
Cash at period end	9.76	7.75	14.9	28.4	23.8	24.2	21.8	32.2	28.5	41.9	43.6	58.1	84.3	123	167

Profitability

Annual · %

Gross margin 75.0% Operating margin -1.8% Net margin -2.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Gross margin	73.0%	71.2%	72.7%	70.5%	71.6%	71.6%	72.2%	73.0%	73.8%	72.3%	75.0%	74.4%	75.2%	74.7%	75.0%
Operating margin	-7.3%	-10.3%	-13.3%	-15.2%	-20.6%	-20.1%	-14.3%	-8.5%	-14.3%	-21.4%	20.1%	-12.9%	-6.7%	-8.6%	-1.8%
Net margin	-8.5%	-10.7%	-14.0%	-15.1%	-21.0%	-21.5%	-15.4%	-10.5%	-15.3%	-23.3%	18.3%	-14.1%	-7.6%	-9.6%	-2.1%

Returns & leverage

Annual · %

ROE -2.4% ROA -1.8% Debt ratio 24.8%

Show table：Returns & leverage

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-34.9%	-53.6%	-26.9%	-15.8%	-17.1%	-18.8%	-16.3%	-10.3%	-14.2%	-14.6%	11.2%	-9.9%	-6.6%	-9.6%	-2.4%
ROA	-16.1%	-22.7%	-15.9%	-12.0%	-12.6%	-12.1%	-9.9%	-6.8%	-7.7%	-7.6%	7.5%	-7.7%	-5.1%	-7.3%	-1.8%
Debt ratio	53.9%	61.5%	35.1%	16.3%	31.6%	39.1%	39.8%	30.1%	55.7%	42.3%	21.4%	22.0%	24.1%	24.4%	24.8%

EPS

Annual · US$

EPS US$-0.24

Show table：EPS

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	—	—	—	—	—	—	—	—	1.07	-1.01	-0.66	-0.95	-0.24

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read AtriCure, Inc. (ATRC) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.